88 related articles for article (PubMed ID: 20619296)
1. Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis.
Chen BY; Qu P; Tie R; Zhu MZ; Zhu XX; Yu J
Regul Pept; 2010 Sep; 164(2-3):139-43. PubMed ID: 20619296
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells.
Lu SY; Wang DS; Zhu MZ; Zhang QH; Hu YZ; Pei JM
Life Sci; 2005 May; 77(1):28-38. PubMed ID: 15848216
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of C-type natriuretic peptide receptor by vasonatrin peptide in cardiac myocytes and fibroblasts.
Lü SY; Zhu MZ; Wang DS; Yu J; Guo HT; Hu YZ; Wei QM
Acta Pharmacol Sin; 2004 Apr; 25(4):424-30. PubMed ID: 15066207
[TBL] [Abstract][Full Text] [Related]
4. Vasonatrin peptide, a new regulator of adiponectin and interleukin-6 production in adipocytes.
Chen BY; Tie R; Qu P; Zhu MZ; Zhu XX; Jin J; Yu J
J Endocrinol Invest; 2011 Nov; 34(10):742-6. PubMed ID: 21625198
[TBL] [Abstract][Full Text] [Related]
5. Vasonatrin peptide, a novel protector of dopaminergic neurons against the injuries induced by n-methyl-4-phenylpyridiniums.
Zhao HK; Chen BY; Chang R; Wang JB; Ni F; Yang L; Dong XC; Sun SH; Zhao G; Fang W; Ma QR; Wang XL; Yu J
Peptides; 2013 Nov; 49():117-22. PubMed ID: 24055805
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
Zhao XY; Zeng X; Li XM; Wang TL; Wang BE
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):963-8. PubMed ID: 19413596
[TBL] [Abstract][Full Text] [Related]
7. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
8. Stephania tetrandra prevents and regresses liver fibrosis induced by carbon tetrachloride in rats.
Chor JS; Yu J; Chan KK; Go YY; Sung JJ
J Gastroenterol Hepatol; 2009 May; 24(5):853-9. PubMed ID: 19220659
[TBL] [Abstract][Full Text] [Related]
9. [Vasonatrin peptide attenuates the enhancement of electrically-induced intracellular calcium transient by isoproterenol in rat cardiac myocytes].
Guo HT; Zhu MZ; Zhang RH; Bi H; Zhang B; Zhang HF; Yu J; Lu SY; Pei JM
Sheng Li Xue Bao; 2004 Jun; 56(3):335-40. PubMed ID: 15224146
[TBL] [Abstract][Full Text] [Related]
10. Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms.
Shi Z; Fu F; Yu L; Xing W; Su F; Liang X; Tie R; Ji L; Zhu M; Yu J; Zhang H
Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H281-90. PubMed ID: 25485902
[TBL] [Abstract][Full Text] [Related]
11. Potential therapeutic effects of a traditional Chinese formulation, BJ-JN, on liver fibrosis induced by carbon tetrachloride in rats.
Zou YH; Yang Y; Li J; Wu Q; Li WP; Lu JT; Roberts MS
J Ethnopharmacol; 2008 Dec; 120(3):452-7. PubMed ID: 18951966
[TBL] [Abstract][Full Text] [Related]
12. C/EBP-α ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo.
Tao LL; Cheng YY; Ding D; Mei S; Xu JW; Yu J; Ou-Yang Q; Deng L; Chen Q; Li QQ; Xu ZD; Liu XP
Apoptosis; 2012 May; 17(5):492-502. PubMed ID: 22307857
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of moderate hypoxia-induced protein synthesis by vasonatrin peptide in cultured neonatal rat cardiomyocytes].
Lu SY; Zhu MZ; Guo HT; Yu J; Wei QM
Sheng Li Xue Bao; 2002 Feb; 54(1):7-11. PubMed ID: 11930233
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis.
Yang JI; Yoon JH; Bang YJ; Lee SH; Lee SM; Byun HJ; Myung SJ; Kim W; Lee HS
Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G126-32. PubMed ID: 19910526
[TBL] [Abstract][Full Text] [Related]
16. Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.
van Beuge MM; Prakash J; Lacombe M; Gosens R; Post E; Reker-Smit C; Beljaars L; Poelstra K
J Pharmacol Exp Ther; 2011 Jun; 337(3):628-35. PubMed ID: 21383021
[TBL] [Abstract][Full Text] [Related]
17. Localization and expression pattern of cytoglobin in carbon tetrachloride-induced liver fibrosis.
Man KN; Philipsen S; Tan-Un KC
Toxicol Lett; 2008 Dec; 183(1-3):36-44. PubMed ID: 18940239
[TBL] [Abstract][Full Text] [Related]
18. Hsian-tsao (Mesona procumbens Heml.) prevents against rat liver fibrosis induced by CCl(4) via inhibition of hepatic stellate cells activation.
Shyu MH; Kao TC; Yen GC
Food Chem Toxicol; 2008 Dec; 46(12):3707-13. PubMed ID: 18929613
[TBL] [Abstract][Full Text] [Related]
19. Stimulatory and Inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/G(i) pathways in rat cultured adipocytes.
Nishikimi T; Iemura-Inaba C; Akimoto K; Ishikawa K; Koshikawa S; Matsuoka H
Regul Pept; 2009 Feb; 153(1-3):56-63. PubMed ID: 19027799
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation.
Taylor MS; Okwuchukwuasanya C; Nickl CK; Tegge W; Brayden JE; Dostmann WR
Mol Pharmacol; 2004 May; 65(5):1111-9. PubMed ID: 15102939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
